Tag Archives: agenda

Agenda Launches For RESI on MaRS

1 Feb

By Lucy Parkinson, Director of Research, LSN

With RESI returning to MaRS in Toronto on April 10th, LSN has prepared a full day agenda of panel and workshop content. In addition to RESI’s high quality one-on-one partnering, attendees will also have the opportunity to hear directly from investors on a variety of topics in early stage fundraising.

For this RESI event in Toronto, we are introducing panels on Tech Transfer and on Government Research Funding, both of which are key topics in the local ecosystem. RESI on MaRS will also see the return of perennial RESI sessions such as Early Stage Therapeutics, Medical Device Investors, Diagnostics and Digital Health. Additionally, RESI will include panels on increasingly popular topic areas – Family Offices, Genomics, and Big Data & Algorithms in Healthcare. Finally, RESI’s Track 4 presents 4 workshops and panels focused on Asia-North America Partnerships, with deep dives on Cross-Border In-Licensing, the Asia Investors Landscape, and more.

RESI on MaRS is a chance to immerse yourself in the early stage life science fundraising world for a day, with full-day partnering and the opportunity to educate yourself on the latest in funding new healthcare technologies and building strategic relationships. If you’d like to attend, sign up now.

RESI JPM 2018: Agenda Announced

30 Nov

By Jessica Yang, Investor Research Analyst, LSN

Biotech and medtech industry executives are drawing up their itineraries for January’s healthcare conference week in San Francisco, and over a thousand attendees are expected to join Life Science Nation for our Redefining Early Stage Investments (RESI) Conference in San Francisco on January 9th!

LSN would now like to announce the agenda for RESI San Francisco. Our event will provide a full day of investor panels and workshops devoted to early-stage life science investment topics. RESI features four tracks of content, including the RESI Asia-North America track, which offers attendees the chance to hear directly from investors and strategic partners from across the Pacific who are seeking North American innovation. These panels will be a must-see for any fundraising entrepreneur in the life science sector.

In addition to RESI’s recurring core sector panels Early Stage Therapeutics, Medical Device Investors, Diagnostics and Healthcare IT, RESI San Francisco will also feature the Big Data & Healthcare Panel. The big data space has increasingly become exciting with its potential to transform healthcare through its cross-correlation to broad applications. In addition, LSN will be bringing back the highly popular panel on Genomics. Genomics is becoming a major technology for life science investment, and the panel will provide the opportunity to learn about the kinds of genomic-related breakthrough that investors are looking to back, and the challenges of investing in the genomics field. Be sure to register now for these tremendous opportunities to learn how investors think about your space.

RESI NYC: Agenda Announced

12 Oct

By Lucy Parkinson, Director of Research, LSN

On November 15th, RESI will come to New York City for the first time ever. As New York’s biotech scene is on the cusp of becoming a major hub, LSN is excited to add RESI as a venue for the city’s emerging biotech and medtech companies to meet with hundreds of global investors.

LSN would now like to announce the agenda for RESI NYC. The event will include 24 investor panels and entrepreneur workshops, including new panels focused on New York biotech and Collaborative Virtual Pharma, and the very first RESI panel of Private Equity & Hedge Funds that invest directly in privately held life science companies. Additionally, a legal workshop will be led by our title sponsor, McDermott Will & Emery. RESI NYC will also feature an updated Asia-North America healthcare investment track, with focus sessions on China Pharma Partners and China Medtech Investors. Check out the full content below. If you want to take part, you can register now.

RESI Boston 2017: Agenda Announced

6 Jul

By Lucy Parkinson, Director of Research, LSN

On September 26th, RESI will come home to Boston. In our year on the road, LSN has expanded our reach into new areas, and it’s time to lead the RESI Tribe back home – including many new investors and exciting emerging technology companies that we’ve met on our travels.

LSN would now like to announce the agenda for RESI Boston. The event will include 24 investor panels and entrepreneur workshops, including new panel content from our sponsors at the NIH, and a new session dedicated to Payers & Providers who invest in early stage technologies. RESI Boston will also feature an Asia-North America healthcare investment track. Check out the full content below. If you want to take part, don’t miss out on your opportunity to catch the early bird price by registering now.

RESI San Diego Agenda Announcement

20 Apr

By Michael Quigley, VP of Market Research, LSN

mike-2

For its first trip to San Diego, the Redefining Early Stage Investments (RESI) conference team will be bringing with it a content rich agenda. RESI’s Biotech and Medtech tracks will feature over 75 investor speakers across 16 panels devoted to specific investor types, technology sectors, or new issues in fundraising. Representatives from family offices, big pharma, VC, angels and more will share with the audience the types of opportunities they are currently looking for as well as what it is like to be on the other side of the negotiating table.

RESI’s Early Stage Workshops track features 4 entrepreneur education workshops, including a new session on 505(b)(2) Strategy led by Ken Phelps, CEO of Camargo.

With our Asia-North America Track, one of our newer and most popular additions, attendees will get the chance to hear directly from investors and strategic partners from across the Pacific looking for North American innovation. These panels will be a must-see for any fundraising entrepreneur in the sector.

We are very excited to bring this diverse pool of investors and speakers to San Diego to share their expertise and experience with the hundreds of fundraising scientist-entrepreneurs who attend RESI. While many of our speaking spots are already allocated, if you or someone you know would want to participate please don’t hesitate to reach out.

RESI on MaRS: Full Agenda Announced

9 Feb

By Michael Quigley, VP of Market Research, LSN

mike-2

As RESI prepares for its second landing on MaRS on April 4th, the team at Life Science Nation is proud to announce the RESI investor panel agenda. With three tracks of panel and workshop content, RESI will feature a wealth of speakers representing all categories of life science investors, from family offices to VCs and angels to big pharma. These panels are a must-see for any fundraising entrepreneur in the sector.

New to Toronto this year LSN will be bringing our latest and highly popular Asia-North America Panel Track, featuring 15 speakers representing Asia based firms seeking to invest in and/or acquire North American life science companies. Entrepreneurs can hear from real investors who are  driving the increase in transpacific investments. See if your technology fits their mandate!

We are excited to be bringing these diverse investor groups into the flourishing innovation hub of Toronto and granting them a unique look into Canada’s innovative healthcare scene. Stay tuned for updates as we continue to confirm speakers and announce panels.

resi-on-mars-agenda

Heading to JPM? Read The RESI SF Agenda

29 Sep

By Dennis Ford, Founder & CEO, LSN

dennis-websit

Biotech and medtech industry executives are already drawing up their itineraries for January’s healthcare conference week in San Francisco. It’s on track to be a busy week for us all. Among the many events and receptions taking place, the Redefining Early Stage Investments Conference (RESI SF) stands alone in providing a targeted opportunity for early stage biotech and medtech companies to schedule up to 16 face-to-face investor meetings in one venue, with the potential for many more ad-hoc investor discussions throughout the day.

Partnering is RESI’s core, but at RESI SF also provides a full day of investor panels and workshops devoted to early stage life science investment topics. We’ll see the return of the RESI Asia-North America track, with content for entrepreneurs who are looking to the Asia Pacific region as a source of investment or future customers. RESI will also feature sessions focused on investors in each main life science technology vertical, and on key investor categories including Family Offices, Angels and Big Pharma, and a new session on Tech Giants in Healthcare.

With a full day of content and meetings, we’re on course for another sellout San Francisco RESI event. Don’t leave it too late to get your ticket.

agendawp

162801425610010374

%d bloggers like this: